Risk factors for hyperglycemia in children with leukemia receiving L-asparaginase and prednisone (Q70550176)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6454771%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

title

Risk factors for hyperglycemia in children with leukemia receiving L-asparaginase and prednisone (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6454771%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1 reference

C H Pui

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6454771%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

G A Burghen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6454771%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

W P Bowman

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6454771%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

R J Aur

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6454771%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

language of work or name

English

0 references

publication date

1 July 1981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6454771%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

12 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6454771%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

volume

99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6454771%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

page(s)

46-50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6454771%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6454771%20AND%20SRC:MED&resulttype=core&format=json

Diabetes in patients treated with asparaginase

12 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

Effect of L-asparaginase on carbohydrate metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

Transient diabetes mellitus secondary to L-asparaginase therapy in acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

Hyperglycemia associated with the therapeutic use of L-asparaginase: possible role of insulin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

Childhood acute lymphocytic leukemia. Study VIII

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

Toxicity of L-asparaginase in children with advanced leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

The effect of L-asparaginase of plasma coagulation factors in acute lymphoblastic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

Comparison of daily versus weekly L-asparaginase for the treatment of childhood acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

Toxicity of E. coli L-asparaginase in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

Potentiation of Diabetogenic Effect of L-Asparaginase by Prednisolone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

Studies of an vitro effect of glucocorticoids on gluconeogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

Glucocorticoid Inhibition of Glucose Uptake by Peripheral Tissues: Old and New Evidence, Molecular Mechanisms, and Physiological Significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

The influence of acute physiological increments of cortisol on fuel metabolism and insulin binding to monocytes in normal humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

Effect of Glucocorticoids on Plasma Insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

The effect of estrogen on intravenous glucose tolerance in woman.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

Obesity, hyperinsulinism, and diabetes mellitus in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients: effects of starvation, refeeding, and dieting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

Correlation between insulin receptor binding in isolated fat cells and insulin sensitivity in obese human subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

Diabetes mellitus in Down's Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

Early-onset diabetes in the general and the Down's syndrome population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

EARLY-ONSET DIABETES MELLITUS IN THE GENERAL AND DOWN'S SYNDROME POPULATIONS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

Down's syndrome and diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

Hyperosmolality complicating diabetes mellitus in childhood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

Nonketotic hyperosmolar diabetic coma in Down's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

Current Views on the Etiology of Insulin-Dependent Diabetes Mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

Diabetes mellitus among first- and second-degree relatives of early onset diabetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

Diabetes mellitus secondary to l-asparaginase therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980955-9

10.1016/S0022-3476(81)80955-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6454771%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1 reference